Bioactivity Studies of Hesperidin and XAV939
| Autor: | Tamer M. M. Abu-Amara, Mohamed S M Nasr, Mohamed E Amer, Doaa A Badr, Yi-Hsu Ju, Aly Fahmy Mohamed, Mohammad Y. Alfaifi, Serag Eldin I. Elbehairi, Ahmed E. Fazary |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
chemistry.chemical_classification
Reactive oxygen species Cell type General Chemical Engineering Cancer General Chemistry Cell cycle medicine.disease Molecular biology Article Chemistry Hesperidin chemistry.chemical_compound chemistry Downregulation and upregulation Cell culture medicine Cytotoxic T cell skin and connective tissue diseases QD1-999 |
| Zdroj: | ACS Omega ACS Omega, Vol 6, Iss 30, Pp 20042-20052 (2021) |
| ISSN: | 2470-1343 |
| Popis: | The present work aimed to evaluate the reactivity of natural bioflavonoid hesperidin (HSP) and synthetically derived XAV939 (XAV) against human hepatocellular carcinoma (HepG2), human breast cancer (MDA-MB231) cancer cell lines, and related molecular and pathological profiles. Data recorded revealed that the cytotoxic potential of the tested products was found to be cell type- and concentration-dependent. The half-maximal inhibitory concentration (IC50) value of the HSP-XAV mixture against MDA-MB231 was significantly decreased in the case of using the HSP-XAV mixture against the HepG2 cell line. Also, there was a significant upregulation of the phosphotumor suppressor protein gene (P53) and proapoptotic genes such as B-cell lymphoma-associated X-protein (Bax, CK, and Caspase-3), while antiapoptotic gene B-cell lymphoma (Bcl-2) was significantly downregulated compared with the untreated cell control. The cell cycle analysis demonstrated that DNA accumulation was detected mainly during the G2/M phase of the cell cycle accompanied with the elevated reactive oxygen species level in the treatment of HepG2 and MDA-MB231 cell lines by the HSP-XAV mixture, more significantly than that in the case of cell control. Finally, our finding suggests that both HSP and XAV939 and their mixture may offer an alternative in human liver and breast cancer therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|